Protana Inc.

LEADFINDER

LEAD FINDER;Scientific research in the field of interactions and binding affinities between proteins and small molecules, the foregoing excluding services performed in the field of agricultural genetics;

LEADFINDER

In the statement, Column 1, line 5, after the word namely developing methodologies should be inserted. In the statement, Column 1, line 7, namely should be deleted.;SCIENTIFIC RESEARCH IN THE FIELD OF DRUG DISCOVERY, NAMELY * DEVELOPING METHODOLOGIES * FOR TESTING CANDIDATE DRUG COMPOUNDS FOR TARGET BINDING ACTIVITY; [ NAMELY, ] ALL OF FOREGOING EXCLUDING SERVICES PERFORMED IN THE FIELD OF AGRICULTURAL GENETICS;

PATHMAP

medical services, namely, diagnosing diseases featuring the following services - developing chemical markers which indicate the presence of disease states; determining biological targets for drugs, in order that the drugs may alleviate disease states and conditions in humans and animals; determining protein and peptide sequences for the purposes of identifying protein or peptide drug targets, and for developing sequencing databases; developing methodologies relating to the foregoing services, namely developing bioanalytical methods to increase the throughput of the identification and characterization of biological substances such as proteins used as biomarkers for a diagnosis or as drug targets, and developing biochemistry process and instrumentation for said foregoing services, and developing simplified methods of performing said foregoing services; and developing methods to reduce the sample sizes needed, and to increase the reliability of assays;

PHOSMAP

BIOTECHNOLOGY AND PHARMACEUTICAL RESEARCH FOR OTHERS, NAMELY, DEVELOPING ASSAYS FOR THE DIAGNOSIS OF DISEASE AND DISEASE PROGRESSION AND FOR THE IDENTIFICATION AND MONITORING OF THE EFFECTS OF DRUG ADMINISTRATION VIA THE MONITORING OF PHOSPHORYLATION-RELATED BIOLOGICAL EVENTS; DEVELOPING METHODOLOGIES FOR BIOCHEMICAL RESEARCH TO BE USED FOR THE MONITORING OF PHOSPHORYLATION-RELATED BIOLOGICAL EVENTS, NAMELY DEVELOPING MARKERS USED TO DETERMINE THE PRESENCE OF DISEASE STATES, DISEASE PROGRESSION, AND EFFECTIVENESS OF DISEASE TREATMENT; DETERMINING BIOLOGICAL PHOSPHORYLATION-RELATED TARGETS FOR DRUGS; DETERMINING PHOSPHORYLATION-RELATED BIOLOGICAL PROCESSES OR PHOSPHORYLATION-RELATED BIOLOGICAL TARGETS WHICH ARE SUSCEPTIBLE TO BEING AFFECTED BY DRUGS; DEVELOPING METHODOLOGIES IN THE FIELD OF PHOSPHORYLATION-RELATED BIOLOGICAL EVENTS AND OR INSTRUMENTS RELATING THERETO IN THE FOREGOING SERVICES;